ZS Pharma Swings For $86 Million IPO

Published: May 16, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ZS Pharma, Inc. (Nasdaq: ZSPH) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of common stock. The proposed maximum offering price is $86.25 million. The company plans to list on the NASDAQ Global Market under the symbol "ZSPH." The offering is being made via J.P. Morgan, Credit Suisse, BMO Capital Markets, and William Blair. View S1 here.

Help employers find you! Check out all the jobs and post your resume.

Back to news